Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc. - ROEverified

OCEL

Price:

$2.7425

Market Cap:

$19.97M

Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering biological therapies for degenerative conditions. Their primary investigational product is Zofin, an acellular biological treatment sourced from perinatal material. This therapeutic is specifically processed to preserve its inherent microRNAs, without the inclusion of any artificial additives or diluents. Zofin is currently undergoing Phase I/II clinical evaluation for its efficacy against COVID-19. Beyond its core drug development, Organicell also offers independent educational, promotional, and marketing solutions to various healthcare sectors, including medical, anti-aging, and regene...[Read more]

Industry

Biotechnology

IPO Date

2016-03-01

Stock Exchange

OTC

Ticker

OCEL

The ROE as of June 2026 (TTM) for Organicell Regenerative Medicine, Inc. (OCEL) is 455.87%

According to Organicell Regenerative Medicine, Inc.’s latest financial reports and current stock price. The company's current ROE is 455.87%. This represents a change of 422.63% compared to the average of 87.23% of the last 4 quarters.

Organicell Regenerative Medicine, Inc. (OCEL) Historical ROE (quarterly & annually)

How has OCEL ROE performed in the past?

The mean historical ROE of Organicell Regenerative Medicine, Inc. over the last ten years is 296.90%. The current 455.87% ROE has changed 53.55% with respect to the historical average. Over the past ten years (40 quarters), OCEL's ROE was at its highest in in the April 2023 quarter at 1.49%. The ROE was at its lowest in in the January 2023 quarter at -354.06%.

Quarterly (TTM)
Annual

Average

296.90%

Median

279.94%

Minimum

-473.90%

Maximum

919.19%

Organicell Regenerative Medicine, Inc. (OCEL) ROE by Quarter and Year

Discovering the peaks and valleys of Organicell Regenerative Medicine, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 668.59%

Maximum Annual ROE = 919.19%

Minimum Annual Increase = -218.80%

Minimum Annual ROE = -473.90%

Quarterly (TTM)
Annual
YearROEChange
2025387.98%36.31%
2024284.63%-49.44%
2023562.98%-218.80%
2022-473.90%-198.54%
2021480.94%-47.68%
2020919.19%668.59%
2019119.59%-56.55%
2018275.25%9.12%
2017252.24%57.62%
2016160.04%-102.78%

Organicell Regenerative Medicine, Inc. (OCEL) Average ROE

How has OCEL ROE performed in the past?

The current ROE of Organicell Regenerative Medicine, Inc. (OCEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

411.87%

5-year avg

248.53%

10-year avg

296.90%

Organicell Regenerative Medicine, Inc. (OCEL) ROE vs. Peers

How is OCEL’s ROE compared to its peers?

Organicell Regenerative Medicine, Inc.’s ROE is greater than Kadimastem Ltd (0.12%), greater than OptiBiotix Health Plc (-52.92%), less than Rapid Dose Therapeutics Corp. (75.85%), less than OKYO Pharma Limited (102.92%), less than Noxopharm Limited (2.51%), greater than Antisense Therapeutics Limited (-110.74%), greater than Sorrento Therapeutics, Inc. (-1904.94%), less than American Hemp Ventures, Inc. (0%), less than Malachite Innovations, Inc. (91.35%), greater than TPCO Holding Corp. (-91.05%),

Build a custom stock screener for Organicell Regenerative Medicine, Inc. (OCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organicell Regenerative Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Organicell Regenerative Medicine, Inc. (OCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Organicell Regenerative Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Organicell Regenerative Medicine, Inc.'s ROE?

How is the ROE calculated for Organicell Regenerative Medicine, Inc. (OCEL)?

What is the highest ROE for Organicell Regenerative Medicine, Inc. (OCEL)?

What is the 3-year average ROE for Organicell Regenerative Medicine, Inc. (OCEL)?

What is the 5-year average ROE for Organicell Regenerative Medicine, Inc. (OCEL)?

How does the current ROE for Organicell Regenerative Medicine, Inc. (OCEL) compare to its historical average?